Chicken egg proteins - Biochemical properties and applications;Białka jaja kurzego - Właściwości biochemiczne i zastosowania

Advances in Clinical and Experimental Medicine

Volumn 14, Issue 5, 2005, Pages 1001-1010

  Gołab, Krzysztof ^a   Warwas, Maria ^a  

^a Katedra i Zakład Biochemii Farmaceutycznej AM ^*  (Poland)

Author keywords

Application; Chicken egg; Proteins; White; Yolk

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AVIDIN; CYSTATIN; EGG PROTEIN; IMMUNOGLOBULIN Y; LIPOSOME; LOW DENSITY LIPOPROTEIN; LYSOZYME; OVALBUMIN; OVOMUCOID; OVOTRANSFERRIN; PHOSVITIN; VERY LOW DENSITY LIPOPROTEIN; VITAMIN BINDING PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; CHICKEN; COSMETIC INDUSTRY; DIAGNOSTIC VALUE; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDUSTRY; FOOD; NONHUMAN; PROTEIN ISOLATION; PROTEIN SYNTHESIS; REVIEW;

AVES;

EID: 28244481873     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Trziszka T (red.): Jajczarstwo. Wydawnictwo Akademii Rolniczej we Wrocławiu, Wrocław 2000.
2. Davis C, Reeves R: High value opportunities from the chicken egg. A report for the Rural Industries Research and Development Corporation 2002, 02/094 (http://www.rirdc.gov.au).
3. Marshall SA, Lazar GA Chirano AJ, Desjarlais JR: Rational design and engineering of therapeutic proteins. Drug Disc Today 2003, 8, 212-221.
4. Pihlanto A, Korhonen H: Bioactive peptides and proteins. Adv Food Nutr Res 2003, 47, 175-276.
5. Stevens L: Egg proteins: what are their functions? Science Progress 1996, 79, 65-87.
6. Stevens L: Egg white proteins. Comp Biochem Physiol 1991, 100B, 1-9.
7. Saxena I, Tayyab S: Protein proteinase inhibitors from avian egg whites. Cell Mol Life Sci 1997, 53, 13-23.
8. Chen GH, Tang SJ, Chen CS Jialg ST: Overexpression of soluble form of chicken cystatin in Escherichia coil and its purification. J Agric Food Chem 2000, 48, 2602-2607.
9. Nilsson M, Wang X, Rodziewicz-Motowidlo S, Janowski R, Lindstrom V, Onnerfjord P, Westermark G, Grzonka Z, Jaskólski M, Grubb A: Prevention of domain swapping inhibitors dimerization and amyloid fibril formation of cystatin C - Use of engineered disulphide bridges, antibodies, and carboxymethypapain to stabilize the monomeric form of cystatin C. J Biol Chem 2004, 270, 2336-24245.
10. Gołab K, Gburek J, Gawel A, Warwas M: Changes in chicken egg white cystatin concentration and isoforms during embryogenesis. Br Poult Sci 2002, 42, 394-398.
11. Wesierska E, Saleh S, Trziszka T, Kopec W, Siewinski M, Korzekwa K: Antimicrobial activity of chicken egg white cystatin. World J Microbiol Biotechnol 2005, 21, 59-64.
12. Korant BD, Towatori T, Ivanoff L, Petteway S Jr, Brzin J, Lanarcic B, Turk V: Viral therapy: prospects for protease inhibitors. J Cell Biochem 1986, 32, 91-95.
13. Tini M, Jewell UR, Camenisch G, Chilov D, Gassmann M: Generation and application of chicken egg-yolk antibodies. Comp Bioch Phys Part A 2001, 131, 569-574.
14. Leung DY, Boguniewicz M: Advances in allergic skin diseases. J Allergy Clin Immunol 2003, 111, Suppl 3, 805-812.
15. Mine Y, Sasaki E, Zhang JW: Reduction of allergenicity modified egg white allergen, ovomucoid third domain. Biochem Biophys Res Commun 2003, 302, 133-137.
16. Usui M, Shimizu T, Goto Y, Saito A, Kato A: Effective reduction of antigenicity of hen egg lysozyme by site-specific glycosylation. FEBS Lett 2004, 557, 169-173.
17. Mine Y: Recent advances in egg protein functionality in the food system. Worlds Poult Sci J 2002, 58, 31-39.
18. Tzeng SS, Jiang ST: Glycosylation modification improved the characteristics of recombinant chicken cystatin and its application on mackrel surimi. J Agric Food Chem 2004, 52, 3212-3216.
19. Cargi A, Ustunol Z, Ryser ET: Antimicrobial edible films and coatings. J Food Protec 2004, 67, 833-848.
20. Pellegrini A, Hulsmeier AJ, Hunziker P, Thomas U: Proteolitic fragments of ovalbumin display antimicrobial activity. Biochem Biophys Acta 2004, 1672, 76-85.
21. Tardi PG, Swartz EN, Harasym TO, Cuffis PR, Bally MB: An immune response to ovoalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin. J Immunol Meth 1997, 210, 137-148.
22. Plate NA, Valuev IL, Sytov GA, Valuev LI: Mucoadhesive polymers with immobilized proteinase inhibitors for oral administration of protein drugs. Biomaterials 2002, 23, 1673-1677.
23. Liang AH, Xue BY, Liang RX, Wang JH, Wang D: Inhibitory effect of egg white lysozyme on ceftizidime-induced release of endotoxin from Pseudomonas aeruginosa. Yao Xue Xue Bao 2003, 38, 801-804.
24. Mine Y, Ma F, Lauriau S: Antimicrobial peptides related by enzymatic hydrolysis of hen egg white lysozyme. J Agric Food Chem 2004, 52, 1088-1094.
25. Ishiguro K, Oku H, Suitani A, Yamamoto Y: Effects of conjugated linoleic acid on anaphylaxis and allergic pruritus. Biol Pharm Bull 2002, 25, 1655-1657.
26. Haas M, Moolenaar F, Meijer DKF, De Zeeuw D: Specific drug delivery to the kidney. Cardiovasc Drugs Ther 2002, 16, 489-495.
27. Zheng F, Cai W, Mitsuhashi T, Vlassara H: Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppress adverse AGE-mediated cellular effects in vitro: A potential AGE sequestration therapy for diabetic nephropathy? Mol Med 2001, 7, 737-747.
28. Warwas M, Kaczmarek U, Gołab K: Udzial proteaz cysteinowych i cystatyn w patogenezie i diagnostyce laboratoryjnej chorób przyzebia. Post Hig Med Dośw 2000, 54, 879-894.
29. Jasir A, Kasprzykowski F, Lindstron V, Scalen C, Grubb A: New antimicrobial peptide active against Gram-positive pathogens. Indian J Med Res 2004, 119, 74-76.
30. Warwas M: Cystatyna C - potencjalne zastosowanie w medycynie. Farm Pol 2002, 58, 648-690.
31. Krol J, Kopitz C, Kirschenhofer A, Schmitt M, Magdolen U, Kruger A, Magdolen: Inhibition of intraperitoneal tumor growth of human ovarian cancer by bi- and trifunctional inhibitors of tumor-associated proteolytic systems. Biol Chem 2003, 384, 1097-1102.
32. Saleh Y, Ziółkowski P, Siewiński M, Milach J, Marszalik P, Rybka J: The combined treatment of transplantable solid mammary carcinoma in Wistar rats by use of photodynamic therapy and cysteine proteinase inhibitor. In Vitro 2001, 15, 351-357.
33. Cegnar M, Kos J, Kristl J: Cystatin incorporated in poly(lactide-co-glycoside) nanoparticles: development and fundamental studies on preservation of its activity. Eur J Pharm Sci 2004, 22, 357-364.
34. Mine Y, Kovacs-Nolan J: Chicken egg yolk antibodies in enteric infectious disease: a review. J Med Food 2002, 5, 159-169.
35. Mano N, Asakawa V, Goto J: Highly selective molecular recognition of biologically active substances using liquid phase separation. Chromatography 2003, 24, 19-34.
36. Alper J: Hatching the golden egg: a new way to make drugs. Science 2003, 300, 729-730.
37. Harvey AJ, Ivarie R: Validating the hen as a bioreactor for the production of exogenous proteins in egg white. Poult Sci 2003, 82, 927-930.
38. McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H: Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep 2004, 7, 728-733.
39. Moździak PE, Petitte JN: Status of transgenic chicken models for developmental biology. Dev Dyn 2004, 229, 414-421.
40. Rapp JC, Harvey AJ, Speksnijder GL, Hu W, Ivariae R: Biologically active human interferon α-2b produced in the egg white of transgenic hens. Transgenic Res 2003, 12, 569-575.